Rep. Michael Guest

Maddy summaryThis bill establishes a process for presidential and vice-presidential candidates requesting Secret Service protection. If denied, the Secretary of Homeland Security must provide written notice within 14 days explaining the reason, and candidates can request reconsideration within another 14 days. The bill also requires Senate confirmation for the Secret Service Director. It directly affects candidates seeking protective details and changes procedural steps for handling such requests, without altering security eligibility standards.

Sustainable Cardiopulmonary Rehabilitation Services in the Home Act This bill permanently allows services relating to cardiac rehabilitation programs, intensive cardiac rehabilitation programs, and pulmonary rehabilitation programs to be furnished via telehealth at a beneficiary's home under Medicare.

Maddy summaryThis bill prohibits federal funds from being used to cover gender transition procedures for individuals under 18, including puberty blockers, hormone therapies (at higher-than-normal doses), and surgeries like hysterectomies or mastectomies. It defines "sex" biologically as male or female and exempts certain medical treatments, such as puberty suppression for precocious puberty or care for genetic disorders of sex development. The policy directly affects minors receiving federally funded healthcare (e.g., Medicaid), restricting coverage for most gender-affirming care. Key mechanisms include funding restrictions and specific medical exceptions, though it does not ban private insurance or out-of-pocket payments.

Maddy summaryHR 809 bans members of the Chinese Communist Party (CCP) and entities controlled by the CCP from purchasing any public or private real estate in the United States. The law applies to all U.S. states, territories, and possessions, including Puerto Rico and Guam. The President must take necessary actions to enforce this prohibition, directly affecting CCP-affiliated individuals and organizations seeking U.S. property investments. It creates a specific restriction on real estate transactions without altering broader foreign ownership rules.

Illegitimate Court Counteraction Act This bill imposes sanctions against foreign persons (individuals and entities) who assist the International Criminal Court (ICC) in investigating, arresting, detaining, or prosecuting certain individuals. The bill categorizes as protected persons (1) any U.S. individual, U.S. entity, or person in the United States, unless the United States is a state party to the Rome Statute of the ICC and provides formal consent to ICC jurisdiction; and (2) any foreign person that is a citizen or lawful resident of a U.S. ally that is not a state party to the Rome Statute or has not consented to ICC jurisdiction. If the ICC attempts to investigate, arrest, detain or prosecute a protected person, the President must impose visa- and property-blocking sanctions against the foreign persons that engaged in or materially assisted in such actions, as well as against foreign persons owned by, controlled by, or acting on behalf of such foreign persons. The President must also apply visa-blocking sanctions to the immediate family members of those sanctioned. Upon enactment, the bill rescinds all funds appropriated for the ICC and prohibits the subsequent use of appropriated funds for the ICC.

Maddy summaryHR 719, the "No Abortion Coverage for Medicaid Act," would prohibit federal Medicaid funds from covering abortions under any Medicaid demonstration projects or waivers, with limited exceptions. It specifically blocks federal financial assistance for abortion services or related expenses (like travel) in Medicaid programs, except in cases of rape or incest, life-threatening pregnancy conditions, or treatment for miscarriage or ectopic pregnancy. This bill directly affects Medicaid recipients in states participating in federal demonstration projects, preventing them from using Medicaid funds for abortion services except under the narrow exceptions listed. The bill aims to permanently align Medicaid funding with the longstanding Hyde Amendment restrictions.

Life at Conception Act This bill declares that the right to life guaranteed by the Constitution is vested in each human being at all stages of life, including the moment of fertilization, cloning, or other moment at which an individual comes into being. Nothing in this bill shall be construed to authorize the prosecution of any woman for the death of her unborn child.

Maddy summaryHR 21, the Born-Alive Abortion Survivors Protection Act, requires medical staff at abortion facilities to provide the same immediate care and hospital admission to any infant born alive during an abortion as they would for any newborn. It mandates reporting failures to provide this care to law enforcement and imposes penalties of up to 5 years in prison for violations, with harsher penalties for intentional killing. The bill also allows women who undergo abortions to sue for civil damages, including triple the abortion cost, and provides for attorney fees. It defines "abortion" to exclude procedures performed after viability to preserve a live birth. This law directly affects healthcare providers at abortion facilities and creates new federal legal obligations for them.

Maddy summaryHR 679 nullifies specific changes the Food and Drug Administration (FDA) made in January 2023 to the safety rules (REMS) for the abortion pill mifepristone. The bill prohibits the FDA from implementing any future safety rules for mifepristone that are substantially similar to the nullified changes. This directly affects the FDA's regulatory authority over mifepristone, which could impact how healthcare providers prescribe the medication and how patients access it. The bill focuses solely on reversing the FDA's 2023 modifications without altering the drug's broader approval status.

Maddy summaryHR 685, the SAVE Moms and Babies Act of 2025, prohibits the FDA from approving new abortion drugs or allowing investigational use of existing ones. It restricts existing abortion drugs to in-person administration by certified healthcare providers in clinics or hospitals (not pharmacies), limits use to pregnancies under 70 days gestation, and requires providers to certify they can handle complications like severe bleeding or ectopic pregnancies. The bill mandates reporting of adverse events (such as hospitalizations or infections) to the FDA without patient identifiers and defines "abortion drug" broadly as any drug intended to terminate pregnancy, excluding specific medical exceptions. This directly affects FDA approval processes, healthcare providers prescribing these drugs, and drug manufacturers.